ロード中...
RNA Interference-Based Cancer Drugs: The Roadblocks, and the “Delivery” of the Promise
Nucleic acid-based therapeutics like synthetic small interfering RNAs have been exploited to modulate gene function, taking advantage of RNA interference (RNAi), an evolutionally conserved biological process. Recently, the world's first RNAi drug was approved for a rare genetic disorder in the...
保存先:
| 出版年: | Nucleic Acid Ther |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Mary Ann Liebert, Inc., publishers
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6461149/ https://ncbi.nlm.nih.gov/pubmed/30562145 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/nat.2018.0762 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|